Sims, Hunter S. and de Andrade Horn, Pedro and Isshiki, Ryota and Lim, Melissa and Xu, Yan and Grubbs, Robert H. and Dai, Mingji (2022) Catalysis-Enabled Concise and Stereoselective Total Synthesis of the Tricyclic Prostaglandin D₂ Metabolite Methyl Ester. Angewandte Chemie International Edition, 61 (5). Art. No. e202115633. ISSN 1433-7851. PMCID PMC8766936. doi:10.1002/anie.202115633. https://resolver.caltech.edu/CaltechAUTHORS:20211207-6355000
![]() |
PDF
- Accepted Version
See Usage Policy. 1MB |
![]() |
PDF
- Supplemental Material
See Usage Policy. 7MB |
![]() |
Crystallographic Info File (CIF)
- Supplemental Material
See Usage Policy. 421kB |
Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20211207-6355000
Abstract
A concise and stereoselective total synthesis of the clinically relevant tricyclic prostaglandin D₂ metabolite (tricyclic-PGDM) methyl ester in racemic form was accomplished in eight steps from a readily available known cyclopentene-diol derivative. The synthesis features a nickel-catalyzed Ueno–Stork-type dicarbofunctionalization to generate two consecutive stereocenters, a palladium-catalyzed carbonylative spirolactonization to build the core oxaspirolactone, and a Z-selective cross-metathesis to introduce the (Z)-3-butenoate side chain, a group challenging to introduce through traditional Wittig protocols and troublesome for the two previous total syntheses. A general Z-selective cross-metathesis protocol to construct (Z)-β,γ-unsaturated esters was also developed that has broad functional group tolerance and high stereoselectivity. Additionally, our synthesis already accumulated 75 mg of valuable material for an ¹⁸O-tricyclic-PGDM-based assay used in clinical settings for inflammation.
Item Type: | Article | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Related URLs: |
| ||||||||||
ORCID: |
| ||||||||||
Alternate Title: | Catalysis-Enabled Concise and Stereoselective Total Synthesis of the Tricyclic Prostaglandin D2 Metabolite Methyl Ester | ||||||||||
Additional Information: | © 2021 Wiley-VCH. Issue Online: 18 January 2022; Version of Record online: 14 December 2021; Accepted manuscript online: 06 December 2021; Manuscript received: 16 November 2021. This work was supported by NSF 2102022. The NIH CA023168 is acknowledged for supporting shared NMR resources to Purdue Center for Cancer Research. H.S. gratefully acknowledges support from the Purdue Drug Discovery Training Program (NIH T32GM125620). The XRD data was collected on a new single-crystal X-ray diffractometer supported by the NSF through the Major Research Instrumentation Program under Grant No. CHE 1625543. The authors declare no conflicts of interest. Data Availability Statement: The data that support the findings of this study are available in the Supporting Information of this article. | ||||||||||
Funders: |
| ||||||||||
Subject Keywords: | Carbonylation; Nickel catalysis; Olefin metathesis; Prostaglandins; Total synthesis | ||||||||||
Issue or Number: | 5 | ||||||||||
PubMed Central ID: | PMC8766936 | ||||||||||
DOI: | 10.1002/anie.202115633 | ||||||||||
Record Number: | CaltechAUTHORS:20211207-6355000 | ||||||||||
Persistent URL: | https://resolver.caltech.edu/CaltechAUTHORS:20211207-6355000 | ||||||||||
Official Citation: | Catalysis-Enabled Concise and Stereoselective Total Synthesis of the Tricyclic Prostaglandin D₂ Metabolite Methyl Ester. H. S. Sims, P. de Andrade Horn, R. Isshiki, M. Lim, Y. Xu, R. H. Grubbs, M. Dai, Angew. Chem. Int. Ed. 2022, 61, e202115633; DOI: 10.1002/anie.202115633 | ||||||||||
Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | ||||||||||
ID Code: | 112270 | ||||||||||
Collection: | CaltechAUTHORS | ||||||||||
Deposited By: | George Porter | ||||||||||
Deposited On: | 10 Dec 2021 22:43 | ||||||||||
Last Modified: | 21 Jan 2022 17:32 |
Repository Staff Only: item control page